Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery
- PMID: 22706835
- DOI: 10.1001/jama.2012.5502
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery
Erratum in
- JAMA. 2012 Jun 27;307(24):2590
Abstract
Context: Of the 200 million adults worldwide who undergo noncardiac surgery each year, more than 1 million will die within 30 days.
Objective: To determine the relationship between the peak fourth-generation troponin T (TnT) measurement in the first 3 days after noncardiac surgery and 30-day mortality.
Design, setting, and participants: A prospective, international cohort study that enrolled patients from August 6, 2007, to January 11, 2011. Eligible patients were aged 45 years and older and required at least an overnight hospital admission after having noncardiac surgery.
Main outcome measures: Patients' TnT levels were measured 6 to 12 hours after surgery and on days 1, 2, and 3 after surgery. We undertook Cox regression analysis in which the dependent variable was mortality until 30 days after surgery, and the independent variables included 24 preoperative variables. We repeated this analysis, adding the peak TnT measurement during the first 3 postoperative days as an independent variable and used a minimum P value approach to determine if there were TnT thresholds that independently altered patients' risk of death.
Results: A total of 15,133 patients were included in this study. The 30-day mortality rate was 1.9% (95% CI, 1.7%-2.1%). Multivariable analysis demonstrated that peak TnT values of at least 0.02 ng/mL, occurring in 11.6% of patients, were associated with higher 30-day mortality compared with the reference group (peak TnT ≤ 0.01 ng/mL): peak TnT of 0.02 ng/mL (adjusted hazard ratio [aHR], 2.41; 95% CI, 1.33-3.77); 0.03 to 0.29 ng/mL (aHR, 5.00; 95% CI, 3.72-6.76); and 0.30 ng/mL or greater (aHR, 10.48; 95% CI, 6.25-16.62). Patients with a peak TnT value of 0.01 ng/mL or less, 0.02, 0.03-0.29, and 0.30 or greater had 30-day mortality rates of 1.0%, 4.0%, 9.3%, and 16.9%, respectively. Peak TnT measurement added incremental prognostic value to discriminate those likely to die within 30 days for the model with peak TnT measurement vs without (C index = 0.85 vs 0.81; difference, 0.4; 95% CI, 0.2-0.5; P < .001 for difference between C index values). The net reclassification improvement with TnT was 25.0% (P < .001).
Conclusion: Among patients undergoing noncardiac surgery, the peak postoperative TnT measurement during the first 3 days after surgery was significantly associated with 30-day mortality.
Comment in
-
Troponin levels and mortality after noncardiac surgery.JAMA. 2012 Sep 26;308(12):1204; author reply 1205. doi: 10.1001/2012.jama.11256. JAMA. 2012. PMID: 23011698 No abstract available.
-
Troponin levels and mortality after noncardiac surgery.JAMA. 2012 Sep 26;308(12):1204-5; author reply 1205. doi: 10.1001/2012.jama.11259. JAMA. 2012. PMID: 23011699 No abstract available.
-
Role of fourth-generation troponin in predicting mortality in noncardiac surgery.JAMA Surg. 2013 Jan;148(1):12-3. doi: 10.1001/jamasurg.2013.607. JAMA Surg. 2013. PMID: 23324833
-
High troponin levels after noncardiac surgery: cause for concern?J Am Geriatr Soc. 2013 Dec;61(12):2228-2229. doi: 10.1111/jgs.12558. J Am Geriatr Soc. 2013. PMID: 24329822 No abstract available.
Similar articles
-
Role of fourth-generation troponin in predicting mortality in noncardiac surgery.JAMA Surg. 2013 Jan;148(1):12-3. doi: 10.1001/jamasurg.2013.607. JAMA Surg. 2013. PMID: 23324833
-
Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery.JAMA. 2017 Apr 25;317(16):1642-1651. doi: 10.1001/jama.2017.4360. JAMA. 2017. PMID: 28444280
-
Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery.Interact Cardiovasc Thorac Surg. 2016 Jul;23(1):133-41. doi: 10.1093/icvts/ivw060. Epub 2016 Mar 16. Interact Cardiovasc Thorac Surg. 2016. PMID: 26984965 Free PMC article.
-
Troponin T level and mortality risk after noncardiac surgery: practical implications of the VISION study.Pol Arch Med Wewn. 2012;122(10):499-503. Pol Arch Med Wewn. 2012. PMID: 23123527 Review.
-
Perioperative Troponin Screening Identifies Patients at Higher Risk for Major Cardiovascular Events in Noncardiac Surgery.Curr Probl Cardiol. 2021 Mar;46(3):100429. doi: 10.1016/j.cpcardiol.2019.05.002. Epub 2019 Jun 29. Curr Probl Cardiol. 2021. PMID: 31326099 Review.
Cited by
-
Catecholamine Vasopressors and the Risk of Atrial Fibrillation After Noncardiac Surgery: A Prospective Observational Study.Drug Des Devel Ther. 2024 Nov 15;18:5193-5202. doi: 10.2147/DDDT.S474818. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39568780 Free PMC article.
-
Results of a German nationwide survey on perioperative cardiac management in vascular surgery.Langenbecks Arch Surg. 2024 Nov 12;409(1):345. doi: 10.1007/s00423-024-03523-5. Langenbecks Arch Surg. 2024. PMID: 39531062 Free PMC article.
-
STRIVE pilot trial: a protocol for a multicentre pragmatic internal pilot randomised controlled trial of Structured TRaining to Improve fitness in a Virtual Environment (STRIVE) before surgery.BMJ Open. 2024 Nov 7;14(11):e093710. doi: 10.1136/bmjopen-2024-093710. BMJ Open. 2024. PMID: 39510784 Free PMC article.
-
Association between stress hyperglycemia ratio and postoperative major adverse cardiovascular and cerebrovascular events in noncardiac surgeries: a large perioperative cohort study.Cardiovasc Diabetol. 2024 Nov 2;23(1):392. doi: 10.1186/s12933-024-02467-w. Cardiovasc Diabetol. 2024. PMID: 39488717 Free PMC article.
-
Perioperative myocardial injury.BJA Educ. 2024 Oct;24(10):352-360. doi: 10.1016/j.bjae.2024.06.001. Epub 2024 Aug 1. BJA Educ. 2024. PMID: 39484008 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
